[ad_1]
But complicated eligibility requirements, reduced testing, potential for drug interactions and the public perception that omicron infections are “not that severe” are all elements that muddle demand for the treatment, Reuters reports. Timothy…
|
Sources 2/ https://www.fiercepharma.com/pharma/pfizers-covid-19-antiviral-paxlovid-hits-worldwide-demand-slump The mention sources can contact us to remove/changing this article |
[ad_2]